Navigation Links
Cobalis Corp. Provides Marketing Update Conference Call for Investors
Date:9/7/2010

IRVINE, Calif., Sept. 7 /PRNewswire-FirstCall/ -- Cobalis Corp. (Pink Sheets: CLSC) (www.cobalis.com) is pleased to announce that with our recent positive development of the PreHistin® distribution network and imminent marketing launch, we will be conducting our first series of investor conference calls.  

Shareholders and investors must RSVP to participate in this conference call, which will be held on Tuesday, September 14, 2010 at 1:15pm PDT (Pacific Daylight Time).  All shareholders can RSVP to participate in the conference call by contacting Cobalis at (949) 260-0023 between 9:00 am and 5:00 pm Pacific Time, Monday through Friday, to get the conference call dial-in number and passcode.

Cobalis Corp. is a specialty pharmaceutical, nutraceutical and preventive healthcare product development and marketing company. Its flagship product, PreHistin® Allergy Defense Formula, The World's FIRST Pre-Histamine, is designed to mitigate overproduction of IgE levels and restore a normal response to seasonal and year-round indoor and outdoor allergens. PreHistin® is available without prescription for both long-term and daily use.

FORWARD LOOKING STATEMENTS

Cobalis Corp., expectation of results and other forward-looking statements contained in this email involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from those expected are the following: business conditions and general economic conditions; competitive factors, such as pricing and marketing efforts; and the pace and success of product research and development. These and other factors may cause expectations to differ.

ABOUT COBALIS CORP—PREHISTIN®Cobalis Corp. is a specialty pharmaceutical, nutraceutical and preventive healthcare product development and marketing company.  Its flagship product, PreHistin® Allergy Defense Formula, The World's FIRST Pre-Histamine, is designed to mitigate overproduction of IgE levels and restore a normal response to seasonal and year-round indoor and outdoor allergens.  PreHistin® is available without prescription for both long-term and daily use.

For PreHistin® product information and ordering please visit at www.PreHistin.com or call toll free 1-877-4POLLEN.  For additional company information please visit the corporate website at www.Cobalis.comCONTACTCobalis Corp.16795 Von Karman, Suite 200Irvine, CA 92606949-260-0023Chas Radovich, PresidentMartin Marion, CEOinfo@cobalis.com  info@prehistin.com
'/>"/>

SOURCE Cobalis Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China PharmaHub Corp. Begins Trading Under Stock Symbol CPHB Instead of WRLC
2. UPDATE: China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
3. China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
4. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2010 Financial Results on August 6, 2010
5. Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance
6. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
7. China PharmaHub Corp. Enters Into Definitive Agreement for Humanized Antibody
8. BioSpecifics Technologies Corp. to Present at Jefferies & Company 2010 Global Life Sciences Conference
9. Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Third Quarter Ended April 30, 2010
10. Cantel Medical Corp. to Present at the 9th Annual Needham Healthcare Conference
11. Cantel Medical Corp. to Present at the Jefferies 2010 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017  GenomeDx Biosciences today ... Information Database) and Decipher® Prostate Cancer Classifier tests will ... Association of Urology (EAU) Congress held March 24 to ... The Annual EAU Congress is Europe,s ... comprehensive research in the urological field. The ...
(Date:3/24/2017)... and GENEVA , March 24, ... World Tuberculosis Day revitalizes efforts to develop sutezolid as ... On World Tuberculosis Day, TB Alliance and the Medicines ... clinical development of sutezolid, an antibiotic drug candidate which ... to the development of sutezolid in combination with other ...
(Date:3/23/2017)... Research and Markets has announced the addition ... Replacement Procedure By Technique, Repair Procedure By Technique, By Region, By ... ... forecasted to grow at a CAGR of 13.35% during 2016-2021 ... rising aging population, growth in population with heart disease and rising ...
Breaking Medicine Technology:
(Date:3/24/2017)... Pennsylvania (PRWEB) , ... March 24, 2017 , ... ... recycling solutions for contaminated soil, dredged material, and hazardous and non-hazardous materials announced ... in Allentown, Pennsylvania. This acquisition will add four additional processing facilities and ...
(Date:3/24/2017)... Farifax, VA (PRWEB) , ... March 24, 2017 , ... ... its 2017 Quest Awards . The annual awards, now in their 12th year, ... marketing peers selects the winners. , In 2016, the awards were retooled to recognize ...
(Date:3/24/2017)... ... 2017 , ... Shamanic healer and teacher Anahata Ananda of ... Awakening, proudly presents her Sacred Peru retreat with world famous shaman and ... during the Summer Solstice will also be her final international retreat, Anahata announced ...
(Date:3/24/2017)... ... , ... The law firm of Enea, Scanlan & Sirignano, LLP, ... Lauren C. Enea has joined the firm as an associate attorney. Ms. Enea, who ... elder law, Medicaid planning and applications, and Wills, Trusts and Estates. Samantha A. ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Finding Christ Through Social Media: ... journal chronicling the writer’s path toward true communion with God. “Finding Christ Through ... is the creation of published author Lea Michelle Johnson, a follower of Christ, ...
Breaking Medicine News(10 mins):